{"Name":"AbGenomics","perma":"abgenomics","BasicInfo":{"funded":"2000-06-01","isClosed":false,"closed":null,"short":"AbGenomics is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases."},"FundingRounds":[{"funding_type":"venture","series":"C","announcedDate":"2014-08-27","moneyRaised":13160000},{"funding_type":"venture","series":"B","announcedDate":"2013-07-18","moneyRaised":9600000},{"funding_type":"venture","series":"a","announcedDate":"2012-06-19","moneyRaised":16850000}],"Acquisitions":[],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"Chief Medical Officer","started":null,"ended":null,"firstName":"Shih-Yao","lastName":"Lin"},{"title":"Chairman & CEO","started":null,"ended":null,"firstName":"Rong-Hwa","lastName":"Lin"}],"PastTeam":[]}
